gadolinium dtpa has been researched along with orantinib in 1 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (orantinib) | Trials (orantinib) | Recent Studies (post-2010) (orantinib) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 110 | 19 | 36 |
| Protein | Taxonomy | gadolinium dtpa (IC50) | orantinib (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 2.186 | |
| Platelet-derived growth factor receptor beta | Mus musculus (house mouse) | 3.6 | |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 1.126 | |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | 3.003 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.028 | |
| Platelet-derived growth factor receptor alpha | Mus musculus (house mouse) | 3.6 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 1.8986 | |
| Aurora kinase B | Homo sapiens (human) | 0.041 | |
| Aurora kinase C | Homo sapiens (human) | 0.21 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boschi, F; D'Onofrio, M; Faccioli, N; Marzola, P; Pozzi Mucelli, R; Sbarbati, A | 1 |
1 other study(ies) available for gadolinium dtpa and orantinib
| Article | Year |
|---|---|
Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
Topics: Adenocarcinoma; Albumins; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Colonic Neoplasms; Contrast Media; Gadolinium DTPA; Indoles; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Microcirculation; Neoplasms, Experimental; Organometallic Compounds; Oxindoles; Propionates; Protein-Tyrosine Kinases; Pyrroles; Rats; Tamoxifen | 2007 |